Interested in joining as a sponsor in 2020? Contact us to learn more!
|
Founding Sponsor, 2017-2020:
|
Silver Sponsor, 2018-2020
|
|
|
Amanda Cashin, Ph.D. is Co-Founder and Head of Illumina Accelerator, a leading company creation engine and investment vehicle focused on building genomics-driven startups. Founded in Fall 2014 in San Francisco, Illumina Accelerator is investing in emerging startups, advancing breakthrough applications in genomics, including applications in therapeutics, women’s health, cancer diagnostics, consumer nutrition, agriculture, synthetic biology, and skin microbiome.
Previously, Amanda was Senior Vice President of Alexandria Venture Investments/Alexandria Real Estate Equities, Inc. In her role, she helped lead Alexandria Venture Investments, which has over $250 million in capital deployed and committed to breakthrough life science and technology companies and leading venture capital funds. Amanda also led a team of life science professionals with strong science and business expertise responsible for industry research, company analysis, business development, and thought leadership limitations to help position Alexandria at the forefront of the industry. She earned a Ph.D. in Chemical Biology from the California Institute of Technology and graduated summa cum laude with a Bachelor's degree in Physical Organic Chemistry from the University of Colorado, Boulder. Her scientific expertise and peer-reviewed publications are in the fields of biochemistry, organic chemistry, physical chemistry, pharmacology, electrophysiology, and neuroscience. |
Chris Haskell, Ph.D., Vice President and Head of the West Coast Innovation Center, Bayer
Dr. Chris Haskell leads Bayer’s West Coast Innovation Center, located in the Mission Bay neighborhood of San Francisco, Calif. The West Coast Innovation Center supports Bayer’s Drug Discovery activities by developing and managing partnerships with U.S. academic research institutions and life science companies. Haskell is also responsible for cultivating life science startups within the CoLaborator, a biotech incubator space adjacent to the West Coast Innovation Center. The CoLaborator, which houses a number of startup life science firms, fosters collaboration between Bayer and emerging innovators. Haskell is also board chair emeritus and current board member of the California Life Science Institute, the San Francisco Bay Area industry trade organization dedicated to fostering entrepreneurship, science education and workforce development in the region. After his graduate work at the University of California, Davis and a postdoctoral fellowship at The Gladstone Institute in San Francisco, Haskell joined the Immunology group at Berlex Biosciences. Since joining Bayer in 2007, Haskell has served in various scientific leadership roles, including the Acting Head of Applied Research, the unit responsible for hemostasis research and drug development. In late 2009, Haskell was named head of Bayer’s Science Hub. In 2017, he assumed oversight for the West Coast Innovation Center. |
Lisa Mendoza, Associate Director, Open Innovation
West Coast Innovation Center, Bayer
Dr. Lisa Mendoza is Associate Director with Bayer’s R&D partnering organization located in San Francisco at Bayer’s West Coast Innovation Center. Dr. Mendoza has identified and pursued partnerships with academic and biotech researchers focused on novel therapeutics of strategic interest to Bayer with a primary focus in cardiology and vascular disease. She has managed strategic alliances focused in benign hematology and Cardio-pulmonary indications and negotiated several master agreements for research collaborations. Most recently, the Alliance with University of Pittsburgh focused in Cardio-pulmonary research was launched in late 2016.
Dr. Mendoza’s responsibilities also include search and evaluation in the US for new therapies in Cardiology, Oncology, Gynecological Therapies and Hemostatic Disorders as well as drug discovery enabling technologies. She supports the company’s incubator space adjacent to Bayer’s Innovation Center, the CoLaborator launched in 2012, to engage and cultivate start-up life sciences companies aligned with Bayer’s interests. In this capacity she has interacted with many emerging biotech and advised on the development of companies as part of the relationship that Bayer’s West Coast Innovation Center has with QB3 and UCSF.
Prior to her role in partnering and alliance management with Bayer, Lisa has had various leadership roles on both small molecule and biologic drug discovery in the field of autoimmunity, resulting in several peer-reviewed journal publications and an Investigational New Drug submission. Lisa spent the first part of her professional career at the University of California, Berkeley, in the Immunology Division of the Molecular Cell Biology department and received her Ph. D. from the University of California in San Diego.
West Coast Innovation Center, Bayer
Dr. Lisa Mendoza is Associate Director with Bayer’s R&D partnering organization located in San Francisco at Bayer’s West Coast Innovation Center. Dr. Mendoza has identified and pursued partnerships with academic and biotech researchers focused on novel therapeutics of strategic interest to Bayer with a primary focus in cardiology and vascular disease. She has managed strategic alliances focused in benign hematology and Cardio-pulmonary indications and negotiated several master agreements for research collaborations. Most recently, the Alliance with University of Pittsburgh focused in Cardio-pulmonary research was launched in late 2016.
Dr. Mendoza’s responsibilities also include search and evaluation in the US for new therapies in Cardiology, Oncology, Gynecological Therapies and Hemostatic Disorders as well as drug discovery enabling technologies. She supports the company’s incubator space adjacent to Bayer’s Innovation Center, the CoLaborator launched in 2012, to engage and cultivate start-up life sciences companies aligned with Bayer’s interests. In this capacity she has interacted with many emerging biotech and advised on the development of companies as part of the relationship that Bayer’s West Coast Innovation Center has with QB3 and UCSF.
Prior to her role in partnering and alliance management with Bayer, Lisa has had various leadership roles on both small molecule and biologic drug discovery in the field of autoimmunity, resulting in several peer-reviewed journal publications and an Investigational New Drug submission. Lisa spent the first part of her professional career at the University of California, Berkeley, in the Immunology Division of the Molecular Cell Biology department and received her Ph. D. from the University of California in San Diego.
Past sponsors:
Our thanks to Linda Elkins and Paul Campbell of the Gore Innovation Center in Silicon Valley for hosting the 2018 Corporate Accelerator Forum.
|
Our thanks to Novozymes and to Riccardo LoCascio and Charles Emrich for sponsoring the Forum in 2017 and 2018, including video and photography.
|
Corporate Accelerator Forum Participants, 2017-2019
Advamed
AGC Glass North America
Alexandria
Applied Materials
AT&T Aspire
BD
Bayer CoLaborator
Boomtown Boulder
Cambridge Design Partnership
Children's Hospital of Los Angeles
Citrix Startup Accelerator (former)
Corning
DuPont
Eastman
Eli Lilly and Company
Google
Gore Innovation Center
Hitachi
IDEO CoLab
Illumina Accelerator
Innovators Program Raleigh (Red Hat/Citrix)
Johnson & Johnson Innovation, JLabs
Kaiser Permanente
Kauffman Fellows
Lonza
Magnify Incubator (UCLA California Nanosystems Institute)
NC RIoT Accelerator
MedTech Innovator
Merck
Mesh Academy, USC
MISTA (Givaudan)
Nordic Innovation House
Novozymes, Inc.
Paideia Enterprises
Renault/Nissan/Mitsubishi
Silicon Valley Bank
TMC Innovation
University Lab Partners
Venture Toolkit
Advamed
AGC Glass North America
Alexandria
Applied Materials
AT&T Aspire
BD
Bayer CoLaborator
Boomtown Boulder
Cambridge Design Partnership
Children's Hospital of Los Angeles
Citrix Startup Accelerator (former)
Corning
DuPont
Eastman
Eli Lilly and Company
Gore Innovation Center
Hitachi
IDEO CoLab
Illumina Accelerator
Innovators Program Raleigh (Red Hat/Citrix)
Johnson & Johnson Innovation, JLabs
Kaiser Permanente
Kauffman Fellows
Lonza
Magnify Incubator (UCLA California Nanosystems Institute)
NC RIoT Accelerator
MedTech Innovator
Merck
Mesh Academy, USC
MISTA (Givaudan)
Nordic Innovation House
Novozymes, Inc.
Paideia Enterprises
Renault/Nissan/Mitsubishi
Silicon Valley Bank
TMC Innovation
University Lab Partners
Venture Toolkit
